Cargando…

Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

As sexual transmission of human immunodeficiency virus-1 (HIV-1) occurs via the mucosa, an ideal HIV-1 vaccine should induce both mucosal and systemic immunity. We therefore sought to evaluate the induction of mucosal responses using a DNA env prime–gp120 protein boost approach in which sequential n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristillo, Anthony D., Ferrari, Maria Grazia, Hudacik, Lauren, Lewis, Brad, Galmin, Lindsey, Bowen, Britany, Thompson, DeVon, Petrovsky, Nikolai, Markham, Phillip, Pal, Ranajit
Formato:	Texto
Lenguaje:	English
Publicado:	Society for General Microbiology 2011
Materias:	Animal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052530/ https://www.ncbi.nlm.nih.gov/pubmed/21169215 http://dx.doi.org/10.1099/vir.0.023242-0

Ejemplares similares

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants
por: Cristillo, AD, et al.
Publicado: (2009)

Nedd4-Mediated Increase in HIV-1 Gag and Env Proteins and Immunity following DNA-Vaccination of BALB/c Mice
por: Lewis, Brad, et al.
Publicado: (2014)

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
por: Lobigs, Mario, et al.
Publicado: (2010)

HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
por: Flamar, Anne-Laure, et al.
Publicado: (2018)

Effectiveness of a ‘hunter’ virus in controlling human immunodeficiency virus type 1 infection
por: García-Ramos, Gisela, et al.
Publicado: (2010)

An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
por: Lapuente, Dennis, et al.
Publicado: (2021)

Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin
por: Petit, Sarah J., et al.
Publicado: (2011)

Host factors determine differential disease progression after infection with nef-deleted simian immunodeficiency virus
por: Sopper, Sieghart, et al.
Publicado: (2014)

Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120
por: Chen, Hongying, et al.
Publicado: (2008)

Epigenetic Priming in Immunodeficiencies
por: Martínez-Cano, Jorge, et al.
Publicado: (2019)

Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
por: Sullivan, David J., et al.
Publicado: (2023)

Prime-Boost Strategies in Mucosal Immunization Affect Local IgA Production and the Type of Th Response
por: Fiorino, Fabio, et al.
Publicado: (2013)

Familiarity with visual stimuli boosts recency bias in macaques
por: Brunet, Nicolas, et al.
Publicado: (2019)

Loss of memory CD4(+) T-cells in semi-wild mandrills (Mandrillus sphinx) naturally infected with species-specific simian immunodeficiency virus SIVmnd-1
por: Greenwood, Edward J. D., et al.
Publicado: (2014)

Immunodeficiency and Mucosal Immunity
por: Cunningham-Rundles, Charlotte
Publicado: (2005)

CD4-Induced epitopes in HIV infection
por: DeVico, Anthony, et al.
Publicado: (2006)

HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost
por: Apostólico, Juliana de Souza, et al.
Publicado: (2016)

Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55(Gag) with the phospholipase C-δ1 pleckstrin homology domain results in infectious pseudovirion production
por: Urano, Emiko, et al.
Publicado: (2008)

Identification of RNA helicases in human immunodeficiency virus 1 (HIV-1) replication – a targeted small interfering RNA library screen using pseudotyped and WT HIV-1
por: Williams, Claire A., et al.
Publicado: (2015)

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
por: Sanchez Alberti, Andrés, et al.
Publicado: (2020)

C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors
por: Hu, Qinxue, et al.
Publicado: (2010)

Upregulation of TRIM5α gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5α genotype has no impact on virus acquisition or vaccination outcome
por: Mattiuzzo, Giada, et al.
Publicado: (2013)

Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon
por: Ahuka-Mundeke, Steve, et al.
Publicado: (2010)

Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats
por: Garraway, Kayode, et al.
Publicado: (2018)

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens
por: Kratochvil, Sven, et al.
Publicado: (2017)

Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)

Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs
por: Odunayo, Adesola, et al.
Publicado: (2022)

Can apps be used to formulate fluid therapy plans in veterinary medicine?
por: Zduoba, Simona Aukse, et al.
Publicado: (2022)

Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
por: Levy, J.K., et al.
Publicado: (2017)

Effect of sucralfate on gastric permeability in an ex vivo model of stress‐related mucosal disease in dogs
por: Hill, Tracy L., et al.
Publicado: (2018)

Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma
por: Marsilio, Sina, et al.
Publicado: (2021)

Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
por: Xing, Zhou, et al.
Publicado: (2009)

Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
por: Buchholz, Ursula, et al.
Publicado: (2023)

Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
por: Yokota, Chieko, et al.
Publicado: (2023)

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs
por: Khanna, C., et al.
Publicado: (2015)

Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway
por: Gai, Ling, et al.
Publicado: (2019)

Multi-phenotype analysis for enhanced classification of 11 herpes simplex virus 1 strains
por: Dweikat, Sarah N., et al.
Publicado: (2022)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3qi92jeheq2vnlpjltkste3bqe